Chromatin remodeling and epigenetic regulation of mesenchymal stem/stromal cells in osteoarthritis
Frontiers in Genetics · 07.08.2026 · 17
DOI: 10.3389/fgene.2026.1877252 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Genetics, online erschienen am 07.08.2026. Verfasst von Mo Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chi…. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) creates a persistently hostile joint microenvironment in which inflammatory, mechanical, metabolic, oxidative, and senescence-related cues alter the behavior of mesenchymal stem/stromal cells (MSCs). These changes are not limited to short-term signaling responses, but they should not be interpreted as fixed or irreversible cellular states. Depending on the duration and intensity of environmental exposure, some MSC responses may be transient and reversible, whereas others may be reinforced through epigenetic and chromatin-state regulation, potentially contributing to impaired chondrogenic differentiation, accelerated cellular senescence, and altered paracrine activity, including extracellular vesicles (EVs)-related functions. In this review, we discuss how DNA methylation, histone modifications, long non-coding RNA (lncRNA)-mediated complex recruitment and RNA modifications, chromatin accessibility, and adenosine triphosphate (ATP)-dependent chromatin remodeling connect OA-related stress with OA-associated functional alterations of MSCs. Particular attention is given to the position of chromatin remodeling within the broader epigenetic network. Rather than acting as a separate mechanism, chromatin remodeling provides a structural layer through which regulatory marks, enhancer activity, nucleosome positioning, and transcription-factor access are translated into transcriptional outcomes. We also distinguish different levels of evidence. Data linking epigenetic regulation to MSC chondrogenesis are relatively strong, whereas direct evidence that specific chromatin events determine cargo loading into EVs remains limited. Chromatin regulators such as histone deacetylases (HDACs), BRG1/SMARCA4, and SMARCA5 may serve as mechanistic entry points, but findings from chondrocytes or general MSC models should not be directly extrapolated to OA-derived MSCs without further validation. Finally, we discuss rejuvenation of MSCs, epigenetic preconditioning, microenvironmental engineering, and optimization of EVs as potential strategies for OA regenerative therapy, while emphasizing product heterogeneity, potency testing, patient stratification, and long-term safety as major barriers to translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
- School of Basic Medical Sciences, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China.
Zitieren
APA
Wu, M., Sheng, C., Zhang, H., Chen, Y., Ma, T., Tong, Y., Xu, P., Tong, P., & Xia, H. (2026). Chromatin remodeling and epigenetic regulation of mesenchymal stem/stromal cells in osteoarthritis. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1877252
Vancouver
Wu M, Sheng C, Zhang H, Chen Y, Ma T, Tong Y, et al. Chromatin remodeling and epigenetic regulation of mesenchymal stem/stromal cells in osteoarthritis. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1877252
BibTeX
@article{Wu2026,
author = {Wu, Mo and Sheng, Cenzhuo and Zhang, Hanhao and Chen, Yuxin and Ma, Tianyou and Tong, Yirui and Xu, Pengchao and Tong, Peijian and Xia, Hanting},
title = {Chromatin remodeling and epigenetic regulation of mesenchymal stem/stromal cells in osteoarthritis},
journal = {Frontiers in Genetics},
year = {2026},
volume = {17},
doi = {10.3389/fgene.2026.1877252}
}
EUVIMED